Ching Tian MS

Ching is a General Manager of Digital Accelerator in Novartis Global Drug Development currently leading the decentralized clinical trial effort. Ching has over twenty years experience from biotech/pharma and CRO. She was most recently at PPD as Vice President of Early Clinical Development Services leading the cross-functional CRO service organization. Prior to this role, she led the technology modernization effort in global pharmacovigilance organization at PPD. She also spent thirteen years at biotech company MedImmune in positions with increasing responsibilities and was lastly Senior Director of Clinical Informatics overseeing Data Management, Statistical Programming, Clinical System Operations, and Strategy.